Article
A systematic review and integrative approach to decode the common molecular link between levodopa response and Parkinson's disease.
BMC medical genomics - 19 Sept 2017
Guin Debleena, Mishra Manish Kumar, Talwar Puneet, Rawat Chitra, Kushwaha Suman S, Kukreti Shrikant, Kukreti Ritushree
Abstract excerpt
BACKGROUND: PD is a progressive neurodegenerative disorder commonly treated by levodopa. The findings from genetic studies on adverse effects (ADRs) and levodopa efficacy are mostly inconclusive. Here, we aim to identify predictive genetic biomarkers for levodopa response (LR) and determine common molecular link with disease susceptibility. A systematic review for LR was conducted for ADR, and drug efficacy,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
